Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

An integrated haptic-enabled virtual reality system for orthognathic surgery planning.

Zaragoza-Siqueiros J, Medellin-Castillo HI, de la Garza-Camargo H, Lim T, Ritchie JM.

Comput Methods Biomech Biomed Engin. 2019 Apr;22(5):499-517. doi: 10.1080/10255842.2019.1566817. Epub 2019 Feb 4.

PMID:
30714408
2.

Reviving Phage Therapy for the Treatment of Cholera.

Bhandare S, Colom J, Baig A, Ritchie JM, Bukhari H, Shah MA, Sarkar BL, Su J, Wren B, Barrow P, Atterbury RJ.

J Infect Dis. 2019 Feb 15;219(5):786-794. doi: 10.1093/infdis/jiy563.

PMID:
30395214
3.

Vibrio cholerae accessory colonisation factor AcfC: a chemotactic protein with a role in hyperinfectivity.

Valiente E, Davies C, Mills DC, Getino M, Ritchie JM, Wren BW.

Sci Rep. 2018 May 30;8(1):8390. doi: 10.1038/s41598-018-26570-7.

4.

Host-specific differences in the contribution of an ESBL IncI1 plasmid to intestinal colonization by Escherichia coli O104:H4.

Giles M, Cawthraw SA, AbuOun M, Thomas CM, Munera D, Waldor MK, La Ragione RM, Ritchie JM.

J Antimicrob Chemother. 2018 Jun 1;73(6):1579-1585. doi: 10.1093/jac/dky037.

PMID:
29506073
5.

The QseG Lipoprotein Impacts the Virulence of Enterohemorrhagic Escherichia coli and Citrobacter rodentium and Regulates Flagellar Phase Variation in Salmonella enterica Serovar Typhimurium.

Cameron EA, Gruber CC, Ritchie JM, Waldor MK, Sperandio V.

Infect Immun. 2018 Mar 22;86(4). pii: e00936-17. doi: 10.1128/IAI.00936-17. Print 2018 Apr.

6.

Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.

Moreira CG, Russell R, Mishra AA, Narayanan S, Ritchie JM, Waldor MK, Curtis MM, Winter SE, Weinshenker D, Sperandio V.

MBio. 2016 Jun 7;7(3). pii: e00826-16. doi: 10.1128/mBio.00826-16.

7.

The evaluation of a novel haptic-enabled virtual reality approach for computer-aided cephalometry.

Medellín-Castillo HI, Govea-Valladares EH, Pérez-Guerrero CN, Gil-Valladares J, Lim T, Ritchie JM.

Comput Methods Programs Biomed. 2016 Jul;130:46-53. doi: 10.1016/j.cmpb.2016.03.014. Epub 2016 Mar 16.

PMID:
27208520
8.

The emergence of Vibrio pathogens in Europe: ecology, evolution, and pathogenesis (Paris, 11-12th March 2015).

Le Roux F, Wegner KM, Baker-Austin C, Vezzulli L, Osorio CR, Amaro C, Ritchie JM, Defoirdt T, Destoumieux-Garzón D, Blokesch M, Mazel D, Jacq A, Cava F, Gram L, Wendling CC, Strauch E, Kirschner A, Huehn S.

Front Microbiol. 2015 Aug 13;6:830. doi: 10.3389/fmicb.2015.00830. eCollection 2015.

9.

Animal Models of Enterohemorrhagic Escherichia coli Infection.

Ritchie JM.

Microbiol Spectr. 2014 Aug;2(4):EHEC-0022-2013. doi: 10.1128/microbiolspec.EHEC-0022-2013. Review.

PMID:
26104195
10.

The metabolic enzyme AdhE controls the virulence of Escherichia coli O157:H7.

Beckham KS, Connolly JP, Ritchie JM, Wang D, Gawthorne JA, Tahoun A, Gally DL, Burgess K, Burchmore RJ, Smith BO, Beatson SA, Byron O, Wolfe AJ, Douce GR, Roe AJ.

Mol Microbiol. 2014 Jul;93(1):199-211. doi: 10.1111/mmi.12651. Epub 2014 Jun 9.

11.

A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.

Lu X, Skurnik D, Pozzi C, Roux D, Cywes-Bentley C, Ritchie JM, Munera D, Gening ML, Tsvetkov YE, Nifantiev NE, Waldor MK, Pier GB.

MBio. 2014 Mar 25;5(2):e00974-14. doi: 10.1128/mBio.00974-14.

12.

Autotransporters but not pAA are critical for rabbit colonization by Shiga toxin-producing Escherichia coli O104:H4.

Munera D, Ritchie JM, Hatzios SK, Bronson R, Fang G, Schadt EE, Davis BM, Waldor MK.

Nat Commun. 2014;5:3080. doi: 10.1038/ncomms4080.

13.

A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation.

Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, Kieff E, Davis BM, Waldor MK.

Cell Rep. 2013 May 30;3(5):1690-702. doi: 10.1016/j.celrep.2013.03.039. Epub 2013 Apr 25.

14.

Fucose sensing regulates bacterial intestinal colonization.

Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V.

Nature. 2012 Dec 6;492(7427):113-7. doi: 10.1038/nature11623. Epub 2012 Nov 18.

15.

Fimbriation and curliation in Escherichia coli O157:H7: a paradigm of intestinal and environmental colonization.

Lloyd SJ, Ritchie JM, Torres AG.

Gut Microbes. 2012 May-Jun;3(3):272-6. doi: 10.4161/gmic.20661. Epub 2012 May 1. Review.

16.

The hydrophilic translocator for Vibrio parahaemolyticus, T3SS2, is also translocated.

Zhou X, Ritchie JM, Hiyoshi H, Iida T, Davis BM, Waldor MK, Kodama T.

Infect Immun. 2012 Aug;80(8):2940-7. doi: 10.1128/IAI.00402-12. Epub 2012 May 14.

17.

Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea.

Ritchie JM, Rui H, Zhou X, Iida T, Kodoma T, Ito S, Davis BM, Bronson RT, Waldor MK.

PLoS Pathog. 2012;8(3):e1002593. doi: 10.1371/journal.ppat.1002593. Epub 2012 Mar 15.

18.

A double, long polar fimbria mutant of Escherichia coli O157:H7 expresses Curli and exhibits reduced in vivo colonization.

Lloyd SJ, Ritchie JM, Rojas-Lopez M, Blumentritt CA, Popov VL, Greenwich JL, Waldor MK, Torres AG.

Infect Immun. 2012 Mar;80(3):914-20. doi: 10.1128/IAI.05945-11. Epub 2012 Jan 9.

19.

An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease.

Ritchie JM, Greenwich JL, Davis BM, Bronson RT, Gebhart D, Williams SR, Martin D, Scholl D, Waldor MK.

Antimicrob Agents Chemother. 2011 Dec;55(12):5469-74. doi: 10.1128/AAC.05031-11. Epub 2011 Sep 26.

20.

RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expression.

Mandlik A, Livny J, Robins WP, Ritchie JM, Mekalanos JJ, Waldor MK.

Cell Host Microbe. 2011 Aug 18;10(2):165-74. doi: 10.1016/j.chom.2011.07.007.

21.

Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 Vibrio cholerae.

Shin OS, Tam VC, Suzuki M, Ritchie JM, Bronson RT, Waldor MK, Mekalanos JJ.

MBio. 2011 Jun 14;2(3):e00106-11. doi: 10.1128/mBio.00106-11. Print 2011.

22.

Back to the future: studying cholera pathogenesis using infant rabbits.

Ritchie JM, Rui H, Bronson RT, Waldor MK.

MBio. 2010 May 18;1(1). pii: e00047-10. doi: 10.1128/mBio.00047-10.

23.

Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins.

Rui H, Ritchie JM, Bronson RT, Mekalanos JJ, Zhang Y, Waldor MK.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4359-64. doi: 10.1073/pnas.0915164107. Epub 2010 Feb 16.

24.

Vibrio cholerae interactions with the gastrointestinal tract: lessons from animal studies.

Ritchie JM, Waldor MK.

Curr Top Microbiol Immunol. 2009;337:37-59. doi: 10.1007/978-3-642-01846-6_2. Review.

PMID:
19812979
25.

Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence.

Kulasekara BR, Jacobs M, Zhou Y, Wu Z, Sims E, Saenphimmachak C, Rohmer L, Ritchie JM, Radey M, McKevitt M, Freeman TL, Hayden H, Haugen E, Gillett W, Fong C, Chang J, Beskhlebnaya V, Waldor MK, Samadpour M, Whittam TS, Kaul R, Brittnacher M, Miller SI.

Infect Immun. 2009 Sep;77(9):3713-21. doi: 10.1128/IAI.00198-09. Epub 2009 Jun 29.

26.

CadA negatively regulates Escherichia coli O157:H7 adherence and intestinal colonization.

Vazquez-Juarez RC, Kuriakose JA, Rasko DA, Ritchie JM, Kendall MM, Slater TM, Sinha M, Luxon BA, Popov VL, Waldor MK, Sperandio V, Torres AG.

Infect Immun. 2008 Nov;76(11):5072-81. doi: 10.1128/IAI.00677-08. Epub 2008 Sep 15.

27.

Targeting QseC signaling and virulence for antibiotic development.

Rasko DA, Moreira CG, Li de R, Reading NC, Ritchie JM, Waldor MK, Williams N, Taussig R, Wei S, Roth M, Hughes DT, Huntley JF, Fina MW, Falck JR, Sperandio V.

Science. 2008 Aug 22;321(5892):1078-80. doi: 10.1126/science.1160354.

28.

Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?

Smith EM, Rubenstein LM, Ritchie JM, Lee JH, Haugen TH, Hamsikova E, Turek LP.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2087-96. doi: 10.1158/1055-9965.EPI-08-0054.

29.

Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma.

Simon JH, Paulino AC, Ritchie JM, Mayr NA, Buatti JM.

Sarcoma. 2003;7(1):1-7. doi: 10.1080/1357714031000114147.

30.

Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.

Shifrin Y, Peleg A, Ilan O, Nadler C, Kobi S, Baruch K, Yerushalmi G, Berdichevsky T, Altuvia S, Elgrably-Weiss M, Abe C, Knutton S, Sasakawa C, Ritchie JM, Waldor MK, Rosenshine I.

J Bacteriol. 2008 Jul;190(14):5063-74. doi: 10.1128/JB.00440-08. Epub 2008 May 23.

31.

Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization.

Ho TD, Davis BM, Ritchie JM, Waldor MK.

Infect Immun. 2008 May;76(5):1858-65. doi: 10.1128/IAI.01688-07. Epub 2008 Mar 3.

32.

EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7.

Ritchie JM, Brady MJ, Riley KN, Ho TD, Campellone KG, Herman IM, Donohue-Rolfe A, Tzipori S, Waldor MK, Leong JM.

Cell Microbiol. 2008 Apr;10(4):836-47. Epub 2007 Dec 6.

33.

Dam methyltransferase is required for stable lysogeny of the Shiga toxin (Stx2)-encoding bacteriophage 933W of enterohemorrhagic Escherichia coli O157:H7.

Murphy KC, Ritchie JM, Waldor MK, Løbner-Olesen A, Marinus MG.

J Bacteriol. 2008 Jan;190(1):438-41. Epub 2007 Nov 2.

34.

Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents.

Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LP.

Pediatr Infect Dis J. 2007 Sep;26(9):836-40.

PMID:
17721381
35.

The operon encoding SubAB, a novel cytotoxin, is present in shiga toxin-producing Escherichia coli isolates from the United States.

Khaitan A, Jandhyala DM, Thorpe CM, Ritchie JM, Paton AW.

J Clin Microbiol. 2007 Apr;45(4):1374-5. Epub 2007 Feb 7. No abstract available.

36.

Cognate CD4+ help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8+ T cells.

Steptoe RJ, Ritchie JM, Wilson NS, Villadangos JA, Lew AM, Harrison LC.

J Immunol. 2007 Feb 15;178(4):2094-103.

37.

Human papillomavirus seropositivity and risks of head and neck cancer.

Smith EM, Ritchie JM, Pawlita M, Rubenstein LM, Haugen TH, Turek LP, Hamsikova E.

Int J Cancer. 2007 Feb 15;120(4):825-32.

38.

In vivo transduction of an Stx-encoding phage in ruminants.

Cornick NA, Helgerson AF, Mai V, Ritchie JM, Acheson DW.

Appl Environ Microbiol. 2006 Jul;72(7):5086-8.

39.

Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth.

Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith JL, Li L, Spitz DR, Oberley LW.

Free Radic Biol Med. 2006 Jul 15;41(2):226-37. Epub 2006 May 4.

PMID:
16814103
40.
41.

Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth.

Lewis A, Du J, Liu J, Ritchie JM, Oberley LW, Cullen JJ.

Clin Exp Metastasis. 2005;22(7):523-32. Epub 2006 Feb 11.

PMID:
16475022
42.

The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.

Racila E, Racila DM, Ritchie JM, Taylor C, Dahle C, Weiner GJ.

Immunogenetics. 2006 Feb;58(1):1-8. Epub 2006 Feb 8.

PMID:
16465510
43.

Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors.

Parker TM, Smith EM, Ritchie JM, Haugen TH, Vonka V, Turek LP, Hamsikova E.

Oral Oncol. 2006 Mar;42(3):288-96.

PMID:
16324878
44.

Gonorrhea and chlamydia infection among women visiting family planning clinics: racial variation in prevalence and predictors.

Einwalter LA, Ritchie JM, Ault KA, Smith EM.

Perspect Sex Reprod Health. 2005 Sep;37(3):135-40.

PMID:
16150661
45.

Prostate cancer and consistency of reporting sexual histories in men over age 50.

Dennis LK, Ritchie JM, Resnick MI.

Prostate Cancer Prostatic Dis. 2005;8(3):243-7.

PMID:
15983628
46.

Edge-based identification of DP-features on free-form solids.

Lim T, Medellin H, Torres-Sanchez C, Corney JR, Ritchie JM, Davies JB.

IEEE Trans Pattern Anal Mach Intell. 2005 Jun;27(6):851-60.

PMID:
15943418
47.

The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer.

Goodheart MJ, Ritchie JM, Rose SL, Fruehauf JP, De Young BR, Buller RE.

Clin Cancer Res. 2005 May 15;11(10):3733-42.

48.

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Juweid ME, Wiseman GA, Vose JM, Ritchie JM, Menda Y, Wooldridge JE, Mottaghy FM, Rohren EM, Blumstein NM, Stolpen A, Link BK, Reske SN, Graham MM, Cheson BD.

J Clin Oncol. 2005 Jul 20;23(21):4652-61. Epub 2005 Apr 18.

PMID:
15837965
49.

Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck.

Wang D, Ritchie JM, Smith EM, Zhang Z, Turek LP, Haugen TH.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):626-32.

50.

HPV prevalence and concordance in the cervix and oral cavity of pregnant women.

Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH.

Infect Dis Obstet Gynecol. 2004 Jun;12(2):45-56.

Supplemental Content

Loading ...
Support Center